Publications by authors named "Egbert F Smit"

100Publications

Capmatinib in Exon 14-Mutated or -Amplified Non-Small-Cell Lung Cancer.

N Engl J Med 2020 09;383(10):944-957

From the Department I of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne and University of Cologne, Cologne (J.W.), Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg, Heidelberg (M.T.), the Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen (T.R.O.), and Hämato-Onkologie Hamburg, Hamburg (E.L.) - all in Germany; the National Hospital Organization Kyushu Cancer Center, Fukuoka (T.S.), Aichi Cancer Center, Nagoya (T.H.), the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo (M.N.), the Department of Respiratory Medicine, Okayama University Hospital, Okayama (K.O.), and the National Kyushu Cancer Center, Fukuoka (R.T.) - all in Japan; the National Cancer Center, Gyeonggi-do (J.-Y.H.), and the Department of Internal Medicine, Seoul National University Hospital, Seoul (T.-M.K.) - both in South Korea; the Hospital Clinic of Barcelona (N.R.), Translational Genomic and Targeted Therapeutics in Solid Tumors (IDIBAPS) (N.R.), and Vall d'Hebron University Hospital-Vall d'Hebron Institute of Oncology (E.F.), Barcelona; David Geffen School of Medicine at UCLA, Los Angeles (E.B.G.); the University of Groningen and University Medical Center Groningen, Groningen (H.J.M.G.), Erasmus MC Cancer Institute, Rotterdam (M.J.), and the Netherlands Cancer Institute, Amsterdam (E.F.S.) - all in the Netherlands; the National Cancer Centre Singapore, Singapore (D.S.W.T.); St. Petersburg Pavlov State Medical University, St. Petersburg, Russia (S.V.O.); University Hospital of Lyon-Sud, Lyon (P.-J.S.), and Novartis Pharma, Rueil-Malmaison (S.L.M.) - both in France; the Respiratory Oncology Unit, University Hospitals KU Leuven, Leuven, Belgium (J.V.); the Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna (M.H.); the Thoracic Oncology Division, European Institute of Oncology, IRCCS, Milan (F.M.); Novartis Pharmaceuticals, East Hanover, NJ (A.R., M.G.); Novartis Pharma, Basel, Switzerland (M.W.-L., M.A.); and Novartis Institutes for BioMedical Research, Cambridge (B.S., O.A.B., X.C.), and Massachusetts General Hospital, Boston (R.S.H.) - both in Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2002787DOI Listing
September 2020

Exposure-Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non-Small Cell Lung Cancer Patients.

Clin Pharmacol Ther 2020 Jul 19. Epub 2020 Jul 19.

Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1989DOI Listing
July 2020

Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.

Int J Mol Sci 2020 Jun 12;21(12). Epub 2020 Jun 12.

Amsterdam UMC, Medical Oncology, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21124192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349683PMC
June 2020

Tepotinib in Non-Small-Cell Lung Cancer with Exon 14 Skipping Mutations.

N Engl J Med 2020 09 29;383(10):931-943. Epub 2020 May 29.

From Memorial Sloan Kettering Cancer Center, New York (P.K.P.); the Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (E.F.), and Dr. Rosell Oncology Institute, Dexeus University Hospital, Quirónsalud Group (S.V.), Barcelona; Centre Hospitaliere Universitaire (CHU) Bordeaux, Service des Maladies Respiratoires, Bordeaux (R.V.), Université de Lille, CHU Lille, Thoracic Oncology Department, Centre National de la Recherche Scientifique, INSERM, Institut Pasteur de Lille, UMR9020-UMR-S 1277-Canther, Lille (A.B.C.), CHU de Toulouse, Institut Universitaire du Cancer de Toulouse, Université Paul Sabatier, Toulouse (J.M.), and Institut de Cancérologie de l'Ouest Rene Gauducheau Centre, Saint-Herblain (H. Senellart) - all in France; Saitama Cancer Center, Saitama (H. Sakai), and the Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.), and the Department of Surgery, Oncology and Gastroenterology, University of Padua and Oncologia Medica 2, Istituto Oncologico Veneto, IRCCS, Padua (P.C.) - both in Italy; Antwerp University Hospital, Edegem, Belgium (J.V.M., J.R.); Asklepios Lung Clinic, Munich-Gauting (N.R.), Pius Hospital Oldenburg, University Medicine Oldenburg, Oldenburg (F.G.), Translational Medicine, Department of Bioinformatics (D.J.), Translational Innovation Platform, Oncology (C.S.), the Department of Biostatistics (R.B.), Translational Medicine, Department of Clinical Biomarkers and Companion Diagnostics (J. Straub), and Global Clinical Development (A.J., J. Scheele), Merck, Darmstadt - all in Germany; the Department of Lung Cancer and Thoracic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (D.K.); Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), the Center for Lung Cancer, National Cancer Center, Goyang (J.-Y.H.), and Chonnam National University Medical School and Hwasun Hospital, Hwasun (Y.-C.K.) - all in South Korea; Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (J.D.P.); the Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville (L.H.); the Faculty of Medicine, School of Medicine, National Yang-Ming University (G.-C.C.), the Division of Chest Medicine, Department of Internal Medicine, Tri-service General Hospital, National Defense Medical Center (C.-L.T.), National Taiwan University Hospital (J.C.-H.Y.), and the Department of Chest Medicine, Taipei Veterans General Hospital, and School of Medicine, National Yang-Ming University (Y.-M.C.), Taipei, and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung (G.-C.C.) - both in Taiwan; the Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam (E.F.S.), and the Department of Pulmonology, University of Groningen and University Medical Center Groningen, Groningen (A.J.W.) - both in the Netherlands; and M.D. Anderson Cancer Center, University of Texas, Houston (J.V.H., X.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2004407DOI Listing
September 2020

Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.

Cell Rep 2020 May;31(5):107588

Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2020.107588DOI Listing
May 2020

Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The Netherlands.

Acta Oncol 2020 Jul 29;59(7):748-752. Epub 2020 Apr 29.

Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2020.1757150DOI Listing
July 2020

Imaging Responses to Immunotherapy with Novel PET Tracers.

J Nucl Med 2020 May 21;61(5):641-642. Epub 2020 Feb 21.

Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.119.236158DOI Listing
May 2020

Pembrolizumab for all PD-L1-positive NSCLC.

Lancet 2019 05 4;393(10183):1776-1778. Epub 2019 Apr 4.

Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, NA 1007MB, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)32559-5DOI Listing
May 2019

Repeatability of [F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients.

EJNMMI Res 2019 Feb 7;9(1):14. Epub 2019 Feb 7.

University of Groningen, University Medical Center Groningen, Department of Nuclear Medicine and Molecular Imaging, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13550-019-0481-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367490PMC
February 2019

Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.

J Proteomics 2019 03 30;196:106-119. Epub 2019 Jan 30.

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2019.01.018DOI Listing
March 2019

High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome.

Oncogene 2019 05 31;38(21):4142-4153. Epub 2019 Jan 31.

Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, de Boelelaan 1118, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-019-0711-zDOI Listing
May 2019

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.

Eur J Cancer 2018 11 24;104:182-187. Epub 2018 Oct 24.

Department of Thoracic Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183138
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.09.012DOI Listing
November 2018

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses.

Lung Cancer 2018 10 30;124:130-134. Epub 2018 Jul 30.

Dept of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Dept of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.07.030DOI Listing
October 2018

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.

Br J Cancer 2018 08 31;119(5):558-564. Epub 2018 Jul 31.

Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0194-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162232PMC
August 2018

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLC.

J Thorac Oncol 2018 08 24;13(8):1222-1226. Epub 2018 Apr 24.

Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.012DOI Listing
August 2018

Prophylactic cranial irradiation for stage IV small cell lung cancer, live longer or reduce morbidity of brain metastases?

J Thorac Dis 2017 Oct;9(10):3572-3575

Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.09.50DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723843PMC
October 2017

PD-L1 IHC in NSCLC with a global and methodological perspective.

Lung Cancer 2017 11 18;113:102-105. Epub 2017 Sep 18.

Department of Thoracic Oncology, Netherlands Cancer Institute, Plesmanlaan 121 1066 CX, Amsterdam, the Netherlands; Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.09.010DOI Listing
November 2017

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.

Clin Cancer Res 2018 01 24;24(1):33-42. Epub 2017 Oct 24.

Department of Pulmonary Diseases, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1921DOI Listing
January 2018

Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best Biomarker.

J Clin Oncol 2017 12 10;35(34):3794-3795. Epub 2017 Oct 10.

Egbert F. Smit and John B.A.G. Haanen, Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.5141
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.5141DOI Listing
December 2017

Quality assessment of positron emission tomography scans: recommendations for future multicentre trials.

Acta Oncol 2017 Nov 22;56(11):1459-1464. Epub 2017 Aug 22.

g Department of Pulmonology, GROW-School for Oncology and Developmental Biology , Maastricht University Medical Centre , Maastricht , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1346824DOI Listing
November 2017

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.

Cancer Cell 2017 08;32(2):238-252.e9

Department of Neurosurgery, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Brain Tumor Center Amsterdam, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, 149 13(th) Street, Charlestown, MA 02129, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381325PMC
August 2017

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Eur Respir J 2017 06 1;49(6). Epub 2017 Jun 1.

Dept of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01838-2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898951PMC
June 2017

Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung Cancer.

Ann Thorac Surg 2017 Aug 26;104(2):436-442. Epub 2017 May 26.

Department of Cardiothoracic Surgery, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.02.055DOI Listing
August 2017

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

J Clin Oncol 2017 Aug 5;35(22):2490-2498. Epub 2017 May 5.

Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.5904DOI Listing
August 2017

Therapeutic approach to treating patients with BRAF-mutant lung cancer: latest evidence and clinical implications.

Ther Adv Med Oncol 2017 Jan 3;9(1):46-58. Epub 2016 Oct 3.

Department of Pulmonary Diseases, VU University Medical Center, and Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834016670555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298452PMC
January 2017

How should "RET positive" NSCLC be treated?

Authors:
Egbert F Smit

Lung Cancer 2017 06 6;108:250-251. Epub 2017 Feb 6.

Dept. Thoracic Oncology, Netherlands Cancer Institute & Dept. Pulmonary Diseases, Vrije Universiteit VU Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.02.006DOI Listing
June 2017

Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.

J Clin Oncol 2017 Jan 5;35(3):314-324. Epub 2016 Dec 5.

Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.8739DOI Listing
January 2017

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer.

Radiat Oncol 2016 Oct 3;11(1):131. Epub 2016 Oct 3.

Department of Radiation Oncology, VU University Medical Center Amsterdam, De Boelelaan 1117, Postbox 7057, 1007 MB, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048455PMC
http://dx.doi.org/10.1186/s13014-016-0706-7DOI Listing
October 2016

Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies.

J Nucl Med 2016 10 26;57(10):1642-1649. Epub 2016 May 26.

Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.173831DOI Listing
October 2016

Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.

Proteomics Clin Appl 2016 07 27;10(7):743-9. Epub 2016 May 27.

OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201600025DOI Listing
July 2016

PD-L1 in non-small-cell lung cancer: the third target for immunotherapy.

Lancet 2016 Apr 10;387(10030):1795-6. Epub 2016 Mar 10.

Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)00700-5DOI Listing
April 2016

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib.

Lung Cancer 2016 Mar 30;93:20-7. Epub 2015 Dec 30.

Department of Radiology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.12.009DOI Listing
March 2016

Peptide-mediated 'miniprep' isolation of extracellular vesicles is suitable for high-throughput proteomics.

EuPA Open Proteom 2016 Jun 22;11:11-15. Epub 2016 Feb 22.

OncoProteomics Laboratory, Dept. Medical Oncology, VUmc-Cancer Center Amsterdam, VU University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euprot.2016.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988555PMC
June 2016

Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply.

Lancet Oncol 2016 Feb;17(2):e42-e43

Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)00028-0DOI Listing
February 2016

Quantitative and Simplified Analysis of 11C-Erlotinib Studies.

J Nucl Med 2016 06 4;57(6):861-6. Epub 2016 Feb 4.

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.165225DOI Listing
June 2016

A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors.

J Thorac Oncol 2016 Apr 9;11(4):593-602. Epub 2016 Jan 9.

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.12.106DOI Listing
April 2016

Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.

J Thorac Oncol 2016 Apr 8;11(4):566-72. Epub 2016 Jan 8.

Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.01.002DOI Listing
April 2016

Lung cancer in 2015: Bypassing checkpoints, overcoming resistance, and honing in on new targets.

Nat Rev Clin Oncol 2016 Feb 31;13(2):75-6. Epub 2015 Dec 31.

Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.223DOI Listing
February 2016

A patient perspective on shared decision making in stage I non-small cell lung cancer: a mixed methods study.

BMC Cancer 2015 Dec 16;15:959. Epub 2015 Dec 16.

Department of Public and Occupational Health, EMGO+ Institute for Health and care research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1974-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682255PMC
December 2015

Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.

Clin Lung Cancer 2017 09 30;18(5):e341-e347. Epub 2015 Nov 30.

Institute for Medical Technology Assessment, Erasmus University, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.11.011DOI Listing
September 2017

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.

Cancer Cell 2015 Nov 29;28(5):666-676. Epub 2015 Oct 29.

Department of Neurosurgery, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA; thromboDx B.V., 1098 EA Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2015.09.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644263PMC
November 2015

Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.

Lancet Oncol 2015 Aug;16(8):e374-5

Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00154-0DOI Listing
August 2015

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

J Thorac Oncol 2015 Oct;10(10):1451-7

*Tumorzentrum, Luzerner Kantonsspital, Luzern, Switzerland; †Hôpital Larrey, Centre Hospital-Universitaire, Université Paul Sabatier, Toulouse, France; ‡Institut Claudius Regaud IUCT-O, Toulouse, France; §Institut Gustave Roussy, Villejuif, France; ¶VU University Medical Center, Amsterdam, The Netherlands; ‖Center of Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; #Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; **Onkologie/Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; ††Medizinische Klinik, St. Claraspital, Basel, Switzerland; ‡‡Service de pneumologie et oncologie thoracique, Hopital Universitaire, Caen, France; §§University Hospital Essen, Essen, Germany; ¶¶University Hospital Zurich, Zurich, Switzerland; ‖‖Clinique Teissier, Valenciennes, France; ##Centre Hospitalier Intercommunal de Creteil, Créteil, France; ***University Hospital Innsbruck, Innsbruck, Austria; †††University Hospital Basel, Basel, Switzerland; ‡‡‡Heidelberg University Medical Center, Mannheim, Germany; §§§Hopital du Haut Lévèque, Pessac, France; ¶¶¶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and ‖‖‖Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000625DOI Listing
October 2015

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Lung Cancer 2015 Sep 6;89(3):255-61. Epub 2015 Jun 6.

Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; Department of Pulmonary Diseases, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.023DOI Listing
September 2015

Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer.

EJNMMI Res 2014 Dec 2;4(1):35. Epub 2014 Aug 2.

Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, Amsterdam, 1081HV, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13550-014-0035-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884046PMC
December 2014

Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment.

Radiother Oncol 2015 Jun 30;115(3):361-6. Epub 2015 May 30.

Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2015.05.006DOI Listing
June 2015

Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?

Lung Cancer 2015 Jul 20;89(1):19-26. Epub 2015 Apr 20.

Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.04.005DOI Listing
July 2015

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice.

EJNMMI Res 2015 20;5:14. Epub 2015 Mar 20.

Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, Amsterdam, 1081 HV The Netherlands ; Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, Amsterdam, 1081 HV The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13550-015-0088-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385286PMC
April 2015

Pharmacotherapy for treatment of lung cancer in the elderly.

Expert Opin Pharmacother 2015 May 22;16(7):1021-34. Epub 2015 Mar 22.

Jeroen Bosch Hospital, Department of Pulmonology , Henri Dunantstraat 1, 5223 GZ 's-Hertogenbosch , The Netherlands +31 0 73 5532615 ; +31 0 73 5532614 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1028357DOI Listing
May 2015

Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer.

J Cancer Res Clin Oncol 2015 Aug 6;141(8):1481-91. Epub 2015 Mar 6.

Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-1935-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469769PMC
August 2015